How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Libreria’s Aaron Hicklin on its new independent book fair Typographia. Plus: the team behind ‘Lyle’ magazine celebrate Vancouver Island and the Gulf Islands. Then: Jeff Divine celebrates five decades ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CFO Sarah Friar confirmed at Goldman Sachs' Communacopia conference that OpenAI's frontier models helped architect the very ...